CClinicalTrials.gg
CompletedNCT05170529Updated Sep 1, 2022

Prevalence of Non-Carious Cervical Lesions in Patient With Gingival Recession and Associated Risk Factors

An observational study in Non-carious Cervical Lesion, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 15 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-09-01.

Sponsored by Cairo University · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
362
Ages
15 Years and older
Sex
All
01

Study summary

The study aims at determining the prevalence of non carious cervical lesions in patients with gingival recession in Egyptian population and associated risk factors including gingival biotype, keratinized tissue width, gingival index, plaque index, occlusal wear grade, sensitivity. and a questionnaire will be filled by patients with another risk factors including age, gender, toothbrush frequency and type, bruxism, gastric reflux, soft drinks, alcohol and citrus fruits. Also OHIP-14 will be answered in a questionnaire form by patients.

Read the detailed description

Dental patients will be recruited in a consecutive manner from diagnostic centre at Cairo University Dentistry faculty. Patients with NCCL will be selected for questionnaires and clinical examination. Thorough oral examination will be done, the full aim of the study will be explained to the patient, and patient acceptance is a must. The questionnaire will be done with face to face interview with the patient will include associated risk factors including gingival biotype, keratinized tissue width, gingival index, plaque index, occlusal wear grade, sensitivity. and a questionnaire will be filled by patients with another risk factors including age, gender, toothbrush frequency and type, bruxism, gastric reflux, soft drinks, alcohol and citrus fruits. Also OHIP-14 will be answered in a questionnaire form by patients including: functional limitations, physical pain, psychological discomfort, physical disability, psychological disability, social disability, handicap. then clinical examination will be done for NCCL using mirror, probe, light of the unit, air tip.

02

Conditions studied

  • Non-carious Cervical Lesion
03

In context

Gingival Recession

402 studies on the registry are indexed under Gingival Recession; 98 are open to participants now.

This study's enrollment of 362 is above the median of 44 across 29 observational studies indexed under Gingival Recession.

Browse Gingival Recession studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

adult Egyptian patients with gingival recession attending the dental diagnostic centre in Cairo university

Inclusion criteria

  • adult patients with NCCL and gingival recession whose age is above 15 years old
  • patients consulting in dental Diagnostic Centre, faculty of dentistry, Cairo University
  • patients provide informed consent

Exclusion criteria

Exclusion Criteria:

  • patients having problem in mouth opening or undergoing intermaxillary fixation where oral examination is not possible
  • patients diagnosed with psychiatric problems
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
362 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. number of patients with non-carious cervical lesions in Egyptian adult patients with gingival recession

    clinical examination

    Time frame: Day 1

Secondary outcomes

  1. Oral health related-quality of life (OHR-QoL) OHIP-14 questionnaire

    questionnaire

    Time frame: Day 1

07

Study locations

1 site
  • Cairo university
    Cairo, 12613, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 1, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05170529
Lead sponsor
Cairo University
Responsible party
Omar Essam Ali (Principle investigator, Cairo University) — Principal investigator
First posted
Dec 28, 2021
Start date
Jan 10, 2022
Primary completion
Jun 18, 2022
Completion
Jun 20, 2022
Last update
Sep 1, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion